secwatch / observer
8-K filed Apr 11, 2025 23:59 UTC ticker OTLK CIK 0001649989
leadership confidence high sentiment neutral materiality 0.50

Outlook Therapeutics awards $237,500 retention bonus to CFO/Interim CEO Kenyon

Outlook Therapeutics, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001558370-25-004726
form_type
8-K
ticker
OTLK
cik
0001649989
company_name
Outlook Therapeutics, Inc.
filed_at
2025-04-11T23:59:59+00:00
discovered_at
2026-05-14T18:02:49.197065+00:00
generated_at
2026-05-23T16:12:26.674971+00:00
sec_items
["5.02", "9.01"]
event_type
leadership
sentiment
neutral
materiality_score
0.5
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001558370-25-004726
json_url
https://secwatch.observer/filing/0001558370-25-004726.json
markdown_url
https://secwatch.observer/filing/0001558370-25-004726.md
text_url
https://secwatch.observer/filing/0001558370-25-004726.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1649989/000155837025004726/0001558370-25-004726-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1649989/000155837025004726/otlk-20250409x8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
Source: SEC EDGAR
accession 0001558370-25-004726

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.